Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial and Mesenchymal Phenotype Conversions in Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-0488
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphoglucose Isomerase/Autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by miR-200 in Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2011English

Higher Autocrine Motility Factor/Glucose-6-Phosphate Isomerase Expression Is Associated With Tumorigenesis and Poorer Prognosis in Gastric Cancer

Cancer Management and Research
Oncology
2018English

Monoclonal Antibodies Against Autocrine Motility Factor Suppress Gastric Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Tumor Cell Autocrine Motility Factor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Integrin Α6β4 Promotes Expression of Autotaxin/Enpp2 Autocrine Motility Factor in Breast Carcinoma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

A Variant of Rabbit Phosphoglucose Isomerase

Biochemical Journal
1970English

Host Microenvironment in Breast Cancer Development: Epithelial–mesenchymal Transition in Breast Cancer Development

Breast Cancer Research
Cancer ResearchOncology
2003English

Fas Signaling Promotes Motility and Metastasis Through Epithelial–mesenchymal Transition in Gastrointestinal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy